Daiwa Securities Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38
Closed -$1K 1368
2025
Q4
$1K Hold
38
﹤0.01% 1351
2025
Q3
$2K Hold
38
﹤0.01% 1279
2025
Q2
$1K Hold
38
﹤0.01% 1275
2025
Q1
$1K Hold
38
﹤0.01% 1242
2024
Q4
$1K Hold
38
﹤0.01% 1262
2024
Q3
$1K Hold
38
﹤0.01% 1256
2024
Q2
$1K Hold
38
﹤0.01% 1297
2024
Q1
$0 Hold
38
﹤0.01% 1340
2023
Q4
$0 Hold
38
﹤0.01% 1375
2023
Q3
$0 Hold
38
﹤0.01% 1326
2023
Q2
$1K Hold
38
﹤0.01% 1290
2023
Q1
$1K Hold
38
﹤0.01% 1272
2022
Q4
$1K Hold
38
﹤0.01% 1285
2022
Q3
$1K Hold
38
﹤0.01% 1306
2022
Q2
$1K Hold
38
﹤0.01% 1310
2022
Q1
$1K Hold
38
﹤0.01% 1324
2021
Q4
$1K Hold
38
﹤0.01% 1349
2021
Q3
$1K Hold
38
﹤0.01% 1277
2021
Q2
$1K Hold
38
﹤0.01% 1204
2021
Q1
$1K Hold
38
﹤0.01% 1214
2020
Q4
$1K Buy
+38
New +$699 ﹤0.01% 1193

Other funds holding PAHC

Daiwa Securities Group's PAHC Position: Q1 2026 in Review

Daiwa Securities Group sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 38 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in PAHC in Q4 2020 and held it in 21 quarters. The position peaked at $2K in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Daiwa Securities Group reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 38 Phibro Animal Health shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Phibro Animal Health in Q4 2020 and held it in 21 quarters.
  • Daiwa Securities Group's Phibro Animal Health position peaked at $2K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.